drugset / Trial / NCT03382106
Smoking Cessation and Functional CT Assessment
Phase 4
Completed
162 enrolled
Eric A. Hoffman
National Heart, Lung, and Blood Institute (NHLBI) · collabNational Institutes of Health (NIH) · collab
RandomizedParallel-groupDouble-blindBasic science
Summary
The investigators will study the effect of pulmonary arterial vasodilation to see if it eliminates indices of persistent lung injury in smokers that are susceptible to emphysema.
Timeline
- Start
- 2018-03-19
- Primary completion
- 2024-09-24
- Completion
- 2024-09-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sildenafil | Unknown | 20 mg | — |